Detalhe da pesquisa
1.
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.
Leukemia
; 37(6): 1379-1383, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085610